Impact of pretransplant co-morbidities on non-relapse mortality and quality of life after allogeneic haematopoietic cell transplantation

被引:0
|
作者
Nakaya, A. [1 ]
Mori, T. [1 ]
Aisa, Y. [1 ]
Yamazaki, R. [1 ]
Mihara, A. [1 ]
Ikeda, Y. [1 ]
Okamoto, S. [1 ]
机构
[1] Keio Univ, Sch Med, Tokyo, Japan
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S47 / S47
页数:1
相关论文
共 50 条
  • [21] Quality of life in patients after allogeneic haematopoietic stem cell transplantation
    Stancheva, N.
    Semenova, E.
    Zubarovskay, N.
    Paina, O.
    Vasilieva, Y.
    Alyansky, A.
    Bagge, D.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S88 - S88
  • [22] Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality
    Liu, J.
    Kong, J.
    Chang, Y. J.
    Chen, H.
    Chen, Y. H.
    Han, W.
    Wang, Y.
    Yan, C. H.
    Wang, J. Z.
    Wang, F. R.
    Chen, Y.
    Zhang, X. H.
    Xu, L. P.
    Liu, K. Y.
    Huang, X. J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (12) : 1121.e9 - 1121.e15
  • [23] Insufficient recovery of thymic function after T-cell depleted allogeneic haematopoietic stem cell transplantation predicts for post-engraftment infections and non-relapse mortality
    Wils, E. -J.
    van der Holt, B.
    Broers, A.
    Gratama, J. W.
    Braakman, E.
    Cornelissen, J. J.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S25 - S26
  • [24] Major ABO mismatch is associated with increased non-relapse mortality in alemtuzumab-conditioned unrelated donor allogeneic haematopoietic stem cell transplantation
    Brierley, C. K.
    Littlewood, T. J.
    Staves, J.
    Danby, R.
    Rowley, L. E.
    Ansari, N.
    Gooding, S.
    Peniket, A. J.
    Medd, P. G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 : 18 - 18
  • [25] Major ABO mismatch is associated with increased non-relapse mortality in Alemtuzumab-conditioned unrelated donor allogeneic haematopoietic stem cell transplantation
    Brierley, C. K.
    Littlewood, T. J.
    Staves, J.
    Danby, R.
    Rowley, L.
    Ansari, N.
    Gooding, S.
    Peniket, A. J.
    Medd, P. G.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S51 - S52
  • [26] Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients
    Solano, Carlos
    Gimenez, Estela
    Luis Pinana, Jose
    Albert, Eliseo
    Vinuesa, Victor
    Carlos Hernandez-Boluda, Juan
    Amat, Paula
    Navarro, David
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (04)
  • [27] Improved outcome and non-relapse mortality after allogeneic haematopoietic stem cell transplantation for children and adolescents with haematological diseases: a three decade analysis from a single institution
    Brissot, E.
    Cahu, X.
    Rialland, F.
    Strullu, M.
    Corradini, N.
    Thomas, C.
    Blin, N.
    Rialland, X.
    Thebaud, E.
    Moreau, P.
    Chevallier, P.
    Milpied, N.
    Harrousseau, J.
    Mechinaud, F.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S277 - S278
  • [28] Elevated plasma level of thrombomodulin early after allogeneic haematopoietic stem cell transplantation is associated with severe acute GVHD and increased risk of non-relapse mortality.
    Takeda, J.
    Aoki, K.
    Maruyama, K.
    Kazuma, Y.
    Nagahata, Y.
    Funayama, Y.
    Yamauchi, N.
    Ono, Y.
    Kato, A.
    Tabata, S.
    Matsushita, A.
    Hashimoto, H.
    Shimizu, N.
    Ishikawa, T.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S179 - S179
  • [29] Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors
    Remberger, M
    Storer, B
    Ringdén, O
    Anasetti, C
    BONE MARROW TRANSPLANTATION, 2002, 29 (05) : 391 - 397
  • [30] Comorbidities Exert Regimen-Specific Effects on Non-Relapse Mortality in Allogeneic Stem Cell Transplantation
    Fein, Joshua
    Labopin, Myriam
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Danylesko, Ivetta
    Nadav, Furie
    Shimoni, Avichai
    Nagler, Arnon
    Shouval, Roni
    BONE MARROW TRANSPLANTATION, 2018, 53 : 16 - 17